A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer (Q79644417)
Jump to navigation
Jump to search
scientific article published on 01 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer |
scientific article published on 01 December 2008 |
Statements
A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer (English)
Michael S Gordon
David Mendelson
Robert Carr
Raymond A Knight
Rod A Humerickhouse
Maria Iannone
Alison T Stopeck
1 December 2008